Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Disease × Bronchoscopy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 7 Carcinoma, Non-Small-Cell Lung 3 Neoplasms 2 Lung Diseases 2 Laryngeal Neoplasms 2 Small Cell Lung Carcinoma 1 Pulmonary Nodule Cm 1 Precancerous Conditions 1 Oropharyngeal Neoplasms 1 Nasopharyngeal Neoplasms 1 Mouth Neoplasms 1 Lung Diseases, Obstructive 1 Hypopharyngeal Neoplasms 1 Hemoptysis 1 Head and Neck Neoplasms 1 Disease 1 Carcinoma, Bronchogenic 1

Interventions

Magnetic Resonance Spectroscopy 4 Prednisone 3 Melphalan 3 Dexamethasone 3 Cyclophosphamide 3 Blood Specimen Collection 3 Biopsy, Fine-Needle 3 fluciclovine F-18 2 Surveys and Questionnaires 2 Positron-Emission Tomography 2 Mammography 2 Lenalidomide 2 Injections 2 Immunohistochemistry 2 Gemcitabine 2 Cytarabine 2 weifuchun 1 vistusertib 1 venetoclax 1 ricolinostat 1 pomalidomide 1 phosphoribosylformylglycinamidine synthetase 1 pembrolizumab 1 ofatumumab 1 obinutuzumab 1 irinotecan sucrosofate 1 ibrutinib 1 gossypol acetic acid 1 glycidol 1 deltacortene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01700647 2017-09-12

Breath Testing in Early and Late Larynx Cancer

Royal Brisbane and Women's Hospital

Disease, Laryngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡